i think big pharma looked at their bottomline, and saw that the money spent "courting" doctors with pens, paper, etc. had a negligible effect on doctors' prescribing habits. recognizing that, they decided to stop... under the guise of "conflict of interest". win-win situation, they save their bottomline, and win the public relations side as well.
with that said, i agree with your overall sentiment.
i think big pharma looked at their bottomline, and saw that the money spent "courting" doctors with pens, paper, etc. had a negligible effect on doctors' prescribing habits. recognizing that, they decided to stop... under the guise of "conflict of interest". win-win situation, they save their bottomline, and win the public relations side as well.
ReplyDeletewith that said, i agree with your overall sentiment.
:)